glp 1 leptin GLP-1RAs attenuated obesity and reversed resistance partly via activating the microbiome-derived inosine/A2A pathway Effects of central GLP‐1 on
Description
2024;10:e143
Even mild but persistent symptoms can lead to treatment discontinuation, particularly in non-diabetic individuals using these agents primarily for weight management, who may have lower thresholds for tolerability than diabetic patients
Tirzepatide starts to lower blood sugar levels shortly after starting treatment, with maximum effects typically seen after several weeks of consistent use
Concentrationresponse curves were generated by three-parameter logistic fitting in Prism 9.0
Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice
J Investig Med 66:710
